← Back to Search

~52 spots leftby Jan 2026
Dry Eye Syndrome > A197 Ophthalmic Solution

A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Aramis Biosciences, Inc.
Prior Safety Data

Trial Summary

What is the purpose of this trial?This trial is testing an eye drop called A197 to see if it is safe and effective for people with Dry Eye Disease. The goal is to find out if it can help reduce the discomfort and vision issues caused by this condition.

Eligibility Criteria

Treatment Details

4Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: A197 Ophthalmic Solution, Low DoseExperimental Treatment1 Intervention
Group II: A197 Ophthalmic Solution, High DoseExperimental Treatment1 Intervention
Group III: Active ComparatorActive Control1 Intervention
Group IV: A197 Vehicle ControlPlacebo Group1 Intervention

Find a clinic near you

Research locations nearbySelect from list below to view details:
Aramis Site 105San Antonio, TX
Aramis Site 115Goodlettsville, TN
Aramis Site 102Newport Beach, CA
Aramis Site 123Cranberry Township, PA
More Trial Locations
Loading ...

Who is running the clinical trial?

Aramis Biosciences, Inc.Lead Sponsor

References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top